Thermo Fisher Scientific Return on Investment 2010-2022 | TMO

Current and historical return on investment (ROI) values for Thermo Fisher Scientific (TMO) over the last 10 years.
Thermo Fisher Scientific ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2022-09-30 $9.07B $71.76B 12.56%
2022-06-30 $9.64B $71.60B 13.89%
2022-03-31 $9.80B $72.41B 14.98%
2021-12-31 $10.03B $73.19B 16.51%
2021-09-30 $10.56B $60.40B 18.91%
2021-06-30 $10.71B $55.63B 19.84%
2021-03-31 $9.94B $53.70B 18.86%
2020-12-31 $7.79B $53.62B 15.22%
2020-09-30 $5.96B $52.92B 12.03%
2020-06-30 $4.48B $50.51B 9.38%
2020-03-31 $4.58B $47.79B 9.87%
2019-12-31 $4.59B $46.75B 10.07%
2019-09-30 $4.51B $45.75B 9.97%
2019-06-30 $4.48B $45.39B 9.95%
2019-03-31 $3.92B $44.51B 8.77%
2018-12-31 $3.78B $45.31B 8.48%
2018-09-30 $3.59B $44.65B 8.10%
2018-06-30 $3.31B $44.15B 7.43%
2018-03-31 $3.13B $44.25B 7.27%
2017-12-31 $2.96B $44.29B 7.19%
2017-09-30 $2.76B $45.82B 7.03%
2017-06-30 $2.67B $37.65B 7.12%
2017-03-31 $2.56B $36.98B 7.04%
2016-12-31 $2.46B $36.91B 6.97%
2016-09-30 $2.39B $38.60B 6.98%
2016-06-30 $2.41B $32.90B 7.45%
2016-03-31 $2.37B $32.58B 7.41%
2015-12-31 $2.34B $32.77B 7.42%
2015-09-30 $2.29B $31.13B 7.25%
2015-06-30 $2.36B $31.34B 7.45%
2015-03-31 $2.11B $30.61B 6.58%
2014-12-31 $2.50B $32.90B 7.49%
2014-09-30 $2.32B $31.90B 7.30%
2014-06-30 $2.07B $33.16B 7.00%
2014-03-31 $2.10B $35.63B 7.79%
2013-12-31 $1.61B $26.36B 6.82%
2013-09-30 $1.56B $23.16B 6.87%
2013-06-30 $1.52B $22.52B 6.76%
2013-03-31 $1.51B $22.32B 6.86%
2012-12-31 $1.48B $22.50B 6.84%
2012-09-30 $1.43B $22.33B 6.73%
2012-06-30 $1.39B $20.84B 6.64%
2012-03-31 $1.29B $21.04B 6.24%
2011-12-31 $1.25B $20.79B 6.34%
2011-09-30 $1.21B $21.31B 6.39%
2011-06-30 $1.19B $19.68B 6.66%
2011-03-31 $1.23B $17.06B 7.07%
2010-12-31 $1.19B $17.39B 6.83%
2010-09-30 $1.16B $17.46B 6.67%
2010-06-30 $1.14B $17.38B 6.52%
2010-03-31 $1.10B $17.41B 6.32%
2009-12-31 $1.00B $17.50B 5.81%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $220.806B $39.211B
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.
Stock Name Country Market Cap PE Ratio
Edwards Lifesciences (EW) United States $47.328B 32.57
Alcon (ALC) Switzerland $34.365B 29.59
STERIS (STE) Ireland $19.157B 23.84
Teleflex (TFX) United States $11.379B 18.46
Fresenius Medical Care AG KGaA (FMS) Germany $9.600B 9.64
Penumbra (PEN) United States $8.008B 1916.82
Globus Medical (GMED) United States $7.483B 38.05
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00